4 (1.4) 86.8 (1.6) 81.8 (1.4) 0.007 0.02 0.001 – PTT (sec) 30.1 (0.4) 26.2 (0.7) 28.3 (0.6) 0.001 0.02 0.01 Procoagulant markers – Fibrinogen (mg/dL) 318.5 (8.6) 301.3 (10.9) 372.4 (11.2) 0.21 0.001 0.001 – TAT (ng/L) 6.2 (0.8) 19.2 (3.1) 6.7 (0.8) 0.002
0.002 0.42 – F1 + 2 (pmol/L) 182.4 (11.8) 558.1 (65.6) 266.8 (19.2) 0.001 0.001 0.001 – FVIII (%) 123.4 (4.8) 228.2 (15.8) 169.2 (6.2) 0.001 0.001 0.001 Fibrinolysis markers – PAI-1 (ng/ml) 14.1 (1.4) 21.7 (15.8) 22.6 (2.4) 0.16 0.86 0.002 – D-dimer (μg/L) 175.5 (22.6) 622.1 (175.4) 421.3 (30.6) 0.003 0.07 0.001 Haemostatic system inhibitors – AT (%) 97.8 (1.7) 92.0 (1.7) 89.1 (1.8) 0.04 0.25 0.001 – protein C signaling pathway (%) 105.2 (3.8) 99.3 (2.7) 88.5 (2.7) 0.18 0.03 0.001 – protein S (%) 95.6 (2.4) 91.2 (2.4) 81.8 (2.6) 0.08 0.01 0.001 Platelet-aggregating properties
– p-selectin (ng/ml) 41.5 (2.7) 40.7 (2.9) 40.2 (2.8) 0.65 0.88 0.18 Values are mean (SD). At the end of surgery (T1), both TIVA-TCI and Selleckchem Captisol BAL patients showed a marked and significant increase in pro-coagulant factors (TAT, F1 + 2 and FVIII) and consequent reduction in haemostatic system inhibitors (AT, PC and PS) compared to the values measured prior to surgery (p ≤ 0.004 for each markers). The greatest increase was RXDX-101 supplier observed in the values of TAT and F1 + 2 (about 3 times compared to T0), while the values of FVIII
increased approximately 30%. F1 + 2 and FVIII slightly reduced at T2 but remained DNA ligase significantly higher than basal levels (p ≤ 0.04 for each markers). Only TAT values returned to pre-anaesthesia values. We observed a corresponding increase in anti-coagulant factors that remains significantly lower than prior to surgery (p = 0.001). Fibrinogen levels significantly decreased at T1 in comparison to the initial values, but rose significantly 24 hours post-surgery in both groups, showing an increase of about 20-30% as compared to T0 values (p = 0.001). Changes in pro-coagulant factors and haemostatic system inhibitors were similar in both TIVA-TCI and BAL patients with no significant differences between the two groups of patients. In regards to the fibrinolysis system, D-dimer concentration in TIVA-TCI group, levels increased about 6-fold at T1 compared to baseline level (p = 0.001, Table 3), while in BAL patients it showed an increase of about 4-fold (p = 0.001, Table 4). Both groups showed a decrease of D-dimer at T2 even if the concentration remained higher than baseline levels (p = 0.001), with no significant differences between TIVA-TCI and BAL patients.